Development and validation of a novel TNM staging N‐classification of oral cavity squamous cell carcinoma
Cancer · 2024-02 · 130 (3) · 410-420
DOI: 10.1002/cncr.35020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 26.09.2023. Verfasst von John R de Almeida und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Princess Margaret Cancer Centre/University Health Network, University of Toronto, Toronto, Ontari…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute, Harry Barberian Scholarship Fund.
Abstract (Originalsprache)
Background
For oral cavity squamous cell carcinoma (OSCC), extent of extranodal extension (ENE) (minor, ≤2 mm; major, >2 mm) is differentially prognostic, whereas limitations exist with the 8th edition of American Joint Committee on Cancer/International Union Against Cancer TNM N‐classification (TNM‐8‐N).
Methods
Resected OSCC patients at four centers were included and extent of ENE was recorded. Thresholds for optimal overall survival (OS) discrimination of lymph node (LN) features were established. After dividing into training and validation sets, two new N‐classifications were created using 1) recursive partitioning analysis (RPA), and 2) adjusted hazard ratios (aHRs) and were ranked against TNM‐8‐N and two published proposals.
Results
A total of 1460 patients were included (pN0: 696; pN+: 764). Of the pN+ cases, 135 (18%) had bilateral/contralateral LNs; 126 (17%) and 244 (32%) had minor and major ENE, and two (0.3%) had LN(s) >6 cm without ENE (N3a). LN number (1 and >1 vs. 0: aHRs, 1.92 [95% confidence interval (CI), 1.44–2.55] and 3.21 [95% CI, 2.44–4.22]), size (>3 vs. ≤3 cm: aHR, 1.88 [95% CI, 1.44–2.45]), and ENE extent (major vs. minor: aHR, 1.40 [95% CI, 1.05–1.87]) were associated with OS, whereas presence of contralateral LNs was not (aHR, 1.05 [95% CI, 0.81–1.36]). The aHR proposal provided optimal performance with these changes to TNM‐8‐N: 1) stratification of ENE extent, 2) elimination of N2c and 6‐cm threshold, and 3) stratification of N2b by 3 cm threshold.
Conclusion
A new N‐classification improved staging performance compared to TNM‐8‐N, by stratifying by ENE extent, eliminating the old N2c category and the 6 cm threshold, and by stratifying multiple nodes by size.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Princess Margaret Cancer Centre/University Health Network, University of Toronto, Toronto, Ontario, Canada.
- Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
- Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
- Department of Otolaryngology-Head and Neck Surgery, Health Sciences North, Sudbury, Ontario, Canada.
- Department of Pathology, University Health Network, Toronto, Ontario, Canada.
- Department of Radiation Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
ORCID-Profile: John R de Almeida, Snehal Patel, Cristina Valero, Bin Xu, Evan M Graboyes
Förderung
- NCI NIH HHS
- National Institutes of Health, National Cancer Institute
- Harry Barberian Scholarship Fund
Zitieren
APA
de Almeida, J. R., Su, J. S., Kolarski, M. M., Truong, T., Weinreb, I., Perez-Ordonez, B., Smith, S. M., Hosni, A., Patel, S., Valero, C., Xu, B., Ghossein, R., Katabi, N., Clark, J., Low, T. H., Gupta, R., Graboyes, E. M., Davies, J., Richardson, M., …, & O'Sullivan, B. (2024). Development and validation of a novel TNM staging N‐classification of oral cavity squamous cell carcinoma. Cancer, 130(3), 410-420. https://doi.org/10.1002/cncr.35020
Vancouver
de Almeida JR, Su JS, Kolarski MM, Truong T, Weinreb I, Perez-Ordonez B, et al. Development and validation of a novel TNM staging N‐classification of oral cavity squamous cell carcinoma. Cancer. 2024;130(3):410-420. doi:10.1002/cncr.35020
BibTeX
@article{deAlmeida2024,
author = {de Almeida, John R and Su, Jie Susie and Kolarski, Mirko Manojlovic and Truong, Tra and Weinreb, Ilan and Perez-Ordonez, Bayardo and Smith, Stephen M and Hosni, Ali and Patel, Snehal and Valero, Cristina and Xu, Bin and Ghossein, Ronald and Katabi, Nora and Clark, Jonathan and Low, Tsu-Hui Hubert and Gupta, Ruta and Graboyes, Evan M and Davies, Joel and Richardson, Mary and Pasham, Vishu and Jester, Rachel and Goldstein, David P and Huang, Shao Hui and Xu, Wei and O'Sullivan, Brian},
title = {Development and validation of a novel TNM staging N‐classification of oral cavity squamous cell carcinoma},
journal = {Cancer},
year = {2024},
volume = {130},
number = {3},
pages = {410--420},
doi = {10.1002/cncr.35020}
}
EUVIMED